Stake:36.90%Shares: 5,502,402CUSIP: 04746L203Class: Common Stock
Item 4 — Purpose of Transaction
The acquisition of securities of the issuer is part of a strategic collaboration as previously disclosed between Sermonix Pharmaceuticals, Inc. and the Issuer, as set forth in the previously disclosed License Agreement and Securities Purchase Agreement.